T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Financials - Benzinga

T2 BIOSYSTEMS INC by T2 Biosystems, Inc.

TTOOOTCEM

Trade with Public

Trade with Public

$0.00050

-0.13-99.63%

At close: Feb 21, 4:00 PM EST

$0.00485

-0.13-96.38%

After Hours: Sep 19, 9:11 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

T2 BIOSYSTEMS INC by T2 Biosystems, Inc. Financials

T2 BIOSYSTEMS INC by T2 Biosystems, Inc. (TTOO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
T2 Biosystems Announces Prelim. Financial Results; Sees Q4 Revenues Of $2.3M And 2024 Revenues Of $8.3M

Benzinga Newsdesk

PRO
T2 Biosystems Expects Q4 2024 sepsis product revenue to be $2.5M to $3.5M.

T2 Biosystems (NASDAQ:TTOO) .

Benzinga Newsdesk

PRO
T2 Biosystems Q3 2024 GAAP EPS $(0.57) Beats $(0.64) Estimate, Sales $1.985M Miss $2.800M Estimate

T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.64) by 10.94 percent. The company reported quarterly sales of $1.985 million which missed the

Benzinga Newsdesk

Earnings Scheduled For November 14, 2024

Benzinga Insights

Insights Ahead: T2 Biosystems's Quarterly Earnings

Benzinga Insights

PRO
T2 Biosystems Sees Q4 Revenue $2.5M-$3.5M Vs $3.7M Est.

Benzinga Newsdesk